Product NDC: | 51808-207 |
Proprietary Name: | Pentagastrin |
Non Proprietary Name: | Pentagastrin |
Active Ingredient(s): | 250 ug/1.6mL & nbsp; Pentagastrin |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51808-207 |
Labeler Name: | AnazaoHealth Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 20120619 |
Package NDC: | 51808-207-01 |
Package Description: | 5 mL in 1 VIAL (51808-207-01) |
NDC Code | 51808-207-01 |
Proprietary Name | Pentagastrin |
Package Description | 5 mL in 1 VIAL (51808-207-01) |
Product NDC | 51808-207 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Pentagastrin |
Dosage Form Name | SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20120619 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | AnazaoHealth Corporation |
Substance Name | PENTAGASTRIN |
Strength Number | 250 |
Strength Unit | ug/1.6mL |
Pharmaceutical Classes |